Chen Jing, Lou Jianshu, Liu Tao, Wu Ru, Dong Xiaowu, He Qiaojun, Yang Bo, Hu Yongzhou
ZJU-ENS Joint Laboratory of Medicinal Chemistry, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China.
Arch Pharm (Weinheim). 2009 Mar;342(3):165-72. doi: 10.1002/ardp.200800179.
A novel series of 2-substituted aminomethyl-9-alkyl-1,2,3,4-tetrahydrocarbazole-1-ones 5a-q was synthesized via aminomethylation of 9-alkyl-1,2,3,4-tetrahydrocarbazole-1-ones 4a-e with hydrochlorides of the respective amines 6a-m. The structures of these newly synthesized compounds were characterized by (1)H-NMR, MS, and elemental analysis. All the compounds were tested for their cytotoxic activity in vitro against four human tumor cell lines including human non-small lung cancer cells (A549), human gastric adenocarcinoma (SGC), human colon cancer cell (HCT116), human myeoloid leukemia cells (K562), and one multi-drug resistant subline (KB-VCR). Most compounds showed moderate to potent cytotoxic activity against the tested cell lines. Preliminary mechanism research indicated that the most promising compound, 2-diethylaminomethyl-9-methyl-1,2,3,4-tetrahydrocarbazole-1-one 5c, exhibited a potential inhibitory effect against microtubule.
通过9-烷基-1,2,3,4-四氢咔唑-1-酮4a-e与相应胺6a-m的盐酸盐进行氨甲基化反应,合成了一系列新型的2-取代氨甲基-9-烷基-1,2,3,4-四氢咔唑-1-酮5a-q。通过¹H-NMR、MS和元素分析对这些新合成化合物的结构进行了表征。测试了所有化合物对四种人类肿瘤细胞系的体外细胞毒性活性,这些细胞系包括人非小肺癌细胞(A549)、人胃腺癌(SGC)、人结肠癌细胞(HCT116)、人髓性白血病细胞(K562)以及一个多药耐药亚系(KB-VCR)。大多数化合物对测试的细胞系表现出中度至强效的细胞毒性活性。初步机制研究表明,最有前景的化合物2-二乙氨基甲基-9-甲基-1,2,3,4-四氢咔唑-1-酮5c对微管具有潜在的抑制作用。